Relapsing multiple sclerosis patients can look to second oral agent
Morrow, T.
Managed Care 22(2): 51-52
2013
ISSN/ISBN: 1062-3388 PMID: 23451542 Document Number: 665037
Document emailed within 1 workday
Related Documents
Losy, J.; Niezgoda, A.; Zaremba, J.ła. 2002: IL-15 is elevated in sera of patients with relapsing-remitting multiple sclerosis Folia Neuropathologica 40(3): 151-153Pokryszko-Dragan, A.; Bilińska, M.łg.; Gruszka, E.; Dubik-Jezierzańska, M. 2005: Clinical assessment of the course of relapsing-remitting multiple sclerosis in patients treated with interferon beta Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 19(113): 654-658
Pietropaolo, V.; Fioriti, D.; Mischitelli, M.; Anzivino, E.; Santini, M.; Millefiorini, E.; Di Rezze, S.; Degener, A.Marta. 2005: Detection of human herpesviruses and polyomaviruses DNA in a group of patients with relapsing-remitting multiple sclerosis New Microbiologica 28(3): 199-203
Cabrera-Gómez, J.A.; Echazábal-Santana, N.; Porrero-Martín, P.; Valenzuela-Silva, C.; Rodríguez, C.A.; Fuentes-Suárez, I.; Pérez-Ruiz, L.; Ramos-Cedeño, A.M.; Cabrera-Núñez, J.A. 2003: Interferon-alpha2b recombinant improved the cognitive dysfunction in patients with relapsing remitting multiple sclerosis Revista de Neurologia 37(3): 214-220
Stelmasiak, Z.; Bartosik-Psujek, H.; Belniak-Legieć, E.; Mitosek-Szewczyk, K. 2000: The effect of cladribine on some parameters of blood and cerebrospinal fluid in patients with relapsing-remitting multiple sclerosis (RR-MS) Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 55: 221-225
Bergamaschi, R.; Versino, M.; Raiola, E.; Citterio, A.; Cosi, V. 1993: High-dose methylprednisolone infusions in relapsing and in chronic progressive multiple sclerosis patients. one year follow-up Acta Neurologica 15(1): 33-43
Popova, E.V.; Brylev, L.V.; Davydovskaia, M.V. 2013: Natalizumab in the treatment of patients with relapsing-remitting multiple sclerosis: the preliminary results of the observational program "Sovet" Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 113(2 Pt 2): 79-82
Le-Page, E.; Leray, E.; Taurin, G.; Coustans, M.; Chaperon, J.; Edan, G. 2006: Mitoxantrone as induction therapy in aggressive relapsing remitting multiple sclerosis: a descriptive analysis of 100 consecutive patients Revue Neurologique (Paris) 162(2): 185-194
Bilińska, M.łg.; Frydecka, I.; Kosmaczewska, A.; Ciszak, L.; Koszewicz, M.; Pokryszko-Dragan, A. 2006: CD40L expression on T CD4+ lymphocytes from peripheral blood in patients with relapsing-remitting and secondary progressive multiple sclerosis Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 20(115): 41-45
Henneberg, A.; Mayle, D.M.; Pfau, J.U.; Hartmann, P.; Elsner, U.; Kornhuber, H.H. 1994: Serum antibodies against brain tissue in multiple sclerosis patients: a frequent phenomenon in chronic progressive, but not relapsing disease course Zeitschrift für Arztliche Fortbildung 88(7-8): 593-596
Mitchell, D.N.; Goswami, K.K.; Taylor, P.; Salsbury, A.J.; Porterfield, J.S.; Micheletti, R.; Lange, L.S.; Jacobs, J.P.; Hockley, D.J.; Taylor-Robinson, D.A. 1979: Failure to isolate a transmissible agent from the bone-marrow of patients with multiple sclerosis Lancet 2(8139): 415-416
Hennemann, A. 2002: Glatiramer for relapsing-remitting multiple sclerosis Medizinische Monatsschrift für Pharmazeuten 25(4): 141-142
Robles-Cedeno, R.; Ramio-Torrenta, L. 2018: Cladribine in the treatment of relapsing multiple sclerosis Revista de Neurologia 67(9): 343-354
Lebrun, C.; Ghetau, G.; Bourg, V.; Chanalet, S.; Chatel, M. 2005: Relapsing remitting multiple sclerosis or multiphasic disseminated encephalomyelitis? Revue Neurologique (Paris) 161(2): 228-233
Millar, J.A. 2019: The cost of teriflunomide in the treatment of relapsing-remitting multiple sclerosis New Zealand Medical Journal 132(1490): 36-41
Bencsik, K.; Rajda, C.; Klivényi, P.; Járdánházy, T.; Török, M.; Vécsei, L. 1999: Treatment of relapsing-remitting multiple sclerosis with interferon beta type 1-b Orvosi Hetilap 140(14): 763-766
Fernández-Fernández, O. 2002: Clinical features of relapsing remitting-multiple sclerosis. Prognostic factors Revista de Neurologia 35(11): 1067-1073
Pierzchała, B.; Łabuz-Roszak, B.; Pierzchała, E.; Tyrpień, K. 2014: Oral health in multiple sclerosis patients Wiadomosci Lekarskie 67(2 Part 1): 93-96
Alcala-Vicente, C.; Perez-Miralles, F.C.; Gascon-Gimenez, F.; Bosca-Blasco, I.; Navarre-Gimeno, A.; Coret-Ferrer, F.; Casanova-Estruch, B. 2017: Treatment of relapsing-remitting multiple sclerosis with fingolimod in routine clinical practice Revista de Neurologia 64(10): 445-453
Zaprianova, E.; Deleva, D.; Bakalska, M.; Filchev, N. 1997: Chronic relapsing experimental allergic encephalomyelitis in Lewis rats as a model of multiple sclerosis Morfologiia 112(6): 25-28